Can I add a small note to this debate. It may not be widely known that Read
is already widely used in the UK in EDI transfers between pathology labs
and family practitioners. Thousands of result reports are electronically
transferred each day in the UK and the tests are almost universally coded
using a subset of the READ system. This work is being progressed on a
National basis and an expanded list of tests and investigations will be
released shortly.
As a UK pathologist I welcome the tie-up between SNOMED and Read as
we may be able to move to move to a standardised nomenclature to
support data sharing between laboratory and clinical systems. With luck
this could unlock to potential to exploit decision support systems such that
laboratories can get beyond number generation and into full diagnostic
support.
For information on PathEDI in the UK see
http://www.leeds.ac.uk/acb/pathedi
Rick Jones
-----Original Message-----
From: Jon Rogers <[log in to unmask]>
To: [log in to unmask] <[log in to unmask]>
Cc: 'Leo Fogarty' <[log in to unmask]>; 'Nick Booth'
<[log in to unmask]>
Date: 16 May 1999 16:55
Subject: FW: SNOMED + Read = "New Works"
>One of many messages on Read and SNOMED on Fam Med at present. - I am
>intrigued by the assertion that the New Work will use SNOMEd RT
>structure -is this true?
>
>-----Original Message-----
>From: [log in to unmask] [mailto:[log in to unmask]] On Behalf
>Of Bryan Goddard
>Sent: 06 May 1999 20:13
>To: [log in to unmask]
>Subject: SNOMED + Read = "New Works"
>
>
> I contacted the College of American Pathologists to find out more
> about their plans for SNOMED with some of the issues that have come up
> in this list serve over the past week. Here's what I gleaned from
> their front line person.
>
> 1. Last month they announced a plan for a two year collaboration with
> the National Health Services, who have bought the US rights to Read,
> to develop a product they have dubbed "New Works" which would include
> the structure of SNOMED, but would incorporate the broader terminology
> of Read so that SNOMED will be more widely usable to all specialties.
>
> 2. CAP does not consider themselves a software vendor. Poor usability
> is a function of the software vendors. They attribute the better
> usability of Read for clinical applications to the software bundle
> that Read comes in. They welcome vendors who will write software that
> will make SNOMED easy for end users to use.
>
> 3. They are 2 months into "beta testing" SNOMED-RT. There is no
> usability testing involved in their beta test.
>
> Although some of this sounds great, I feel at a loss as to how we
> family physicians can influence the developments so that someone pays
> attention to usability in real time clinical applications that
> clinicians in productivity environments will actually use.
>
> Bryan
>
> Bryan L. Goddard, M.D.
> Wilson Family Practice Residency
>
>
Dr Rick Jones
Director of Chemical Pathology and Immunology
Institute of Pathology
Tel:(44)-113-233-5677
Fax:(44)-113-233-5672
http://www.acb.org.uk
http://www.yichi.org.uk
http://www.leeds.ac.uk/rdinfo //Winner - Best Health Database HC99
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
|